Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
November 03, 2023 12:00 ET
|
Telesis Bio
SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp®...
Cloning and Mutagenesis Market to hit USD 14.6 billion by 2032, says Global Market Insights Inc.
August 07, 2023 22:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Cloning And Mutagenesis Market size is expected to be worth USD 14.6 billion by 2032. The industry expansion is backed by a wide range of...
Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit
May 22, 2023 12:00 ET
|
Telesis Bio
SAN DIEGO, May 22, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its...
Codex DNA Announces Plan to Change Corporate Name to Telesis Bio
October 12, 2022 09:00 ET
|
Codex DNA, Inc.
SAN DIEGO, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, today announced a plan to change its Company name to...
Codex DNA weitet Anwendung der firmeneigenen Fehlerkorrekturtechnologie aus
October 04, 2022 09:00 ET
|
Codex DNA, Inc.
SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), ein Pionier im Bereich automatisierter Tischsysteme für die synthetische Biologie, gab heute die Markteinführung der...
Codex DNA étend l'application de la technologie exclusive de correction des erreurs
October 04, 2022 09:00 ET
|
Codex DNA, Inc.
SAN DIEGO, 04 oct. 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ : DNAY), un pionnier des systèmes de paillasse automatisés de biologie synthétique, a annoncé aujourd'hui le lancement commercial...
Codex DNA Expands Application of Proprietary Error Correction Technology
October 04, 2022 09:00 ET
|
Codex DNA, Inc.
SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced commercial release of BioXp® Error-corrected...
Codex DNA Showcases Next Generation Automated Synthetic Biology Workstation at World of Technology & Science in Utrecht, Netherlands
September 26, 2022 07:00 ET
|
Codex DNA, Inc.
SAN DIEGO, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, will showcase its recently released BioXp™ 9600 system at the...
Codex DNA Debuts Next-Generation Automated Synthetic Biology Workstation
September 19, 2022 07:00 ET
|
Codex DNA, Inc.
SAN DIEGO, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced commercial release and first shipment of the...